Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06294574 · ClinicalTrials.gov registry record · NA

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

A NA study of Breast Neoplasm, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT06294574 is a NA study of Breast Neoplasm that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 150 participants, roughly in line with the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06294574, a NA study of Breast Neoplasm, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test how successful the retrieval rate of the new HydroMARK Plus Breast Biopsy Site Marker in comparison to HydroMARK.

Conditions Studied

Interventions

  • DEVICE HydroMARK Plus Clip

Study Locations (1)

Alabama

  • The Kirklin Clinic - Birmingham

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-08-05
Est. Completion 2027-12
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06294574

The ClinicalTrials.gov registry entry for NCT06294574 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 157-participant average among 26 other Breast Neoplasm trials with a reported enrollment target. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which HydroMARK Plus Clip is the first listed.

NCT06294574 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06294574 about?

NCT06294574 is a clinical study titled "Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction". The purpose of the study is to test how successful the retrieval rate of the new HydroMARK Plus Breast Biopsy Site Marker in comparison to HydroMARK.

What is the current status of trial NCT06294574?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-08-05. Estimated completion is 2027-12.

What conditions does trial NCT06294574 study?

This clinical trial studies the following conditions: Breast Neoplasm.

What interventions are being tested in trial NCT06294574?

The interventions under investigation include: HydroMARK Plus Clip (DEVICE).

Who is sponsoring clinical trial NCT06294574?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06294574 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.